The association of nutrient intake with the risk of amyotrophic lateral sclerosis (ALS) was investigated in a population-based case-control study conducted in three counties of western Washington State from 1990 to 1994. Incident ALS cases (n = 161) were identified and individually matched on age and gender to population controls (n = 321). A self-administered food frequency questionnaire was used to assess nutrient intake. Conditional logistic regression analysis was used to compute odds ratios adjusted for education, smoking, and total energy intake. The authors found that dietary fat intake was associated with an increased risk of ALS (highest vs. lowest quartile, fiber-adjusted odds ratio (OR) = 2.7, 95% confidence interval (Cl): 0.9, 8.0; p for trend = 0.06), while dietary fiber intake was associated with a decreased risk of ALS (highest vs. lowest quartile, fat-adjusted OR = 0.3, 95% Cl: 0.1, 0.7; p for trend = 0.02). Glutamate intake was associated with an increased risk of ALS (adjusted OR for highest vs. lowest quartile = 3.2, 95% Cl: 1.2, 8.0; p for trend < 0.02). Consumption of antioxidant vitamins from diet or supplement sources did not alter the risk. The positive association with glutamate intake is consistent with the etiologic theory that implicates glutamate excitotoxicity in the pathogenesis of ALS, whereas the associations with fat and fiber intake warrant further study and biologic explanation. Am J Epidemiol 2000;151:164-73.
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amyotrophic lateral sclerosis; case-control studies; diet; dietary fats; dietary fiber; epidemiologic factors; risk factors Amyotrophic lateral sclerosis (ALS) is an adultonset neurodegenerative disorder. Unlike the more common neurodegenerative disorders Alzheimer's disease and Parkinson's disease, ALS is rapidly progressive, with death occurring after a median of 2-3 years (1) . Exciting progress in ALS research has been made in the past decade, with evidence accumulating that injury caused by free radicals (2) (3) (4) (5) , environmental neurotoxicants (6, 7) , glutamate excitotoxicity (8, 9) , or a cumulative effect of more than one of these factors (4, 10) may be important in the pathogenesis of ALS.
Information is limited on the role of diet in the etiology of ALS. Although previous case-control studies have investigated case-control differences in consumption of a few food items (11) (12) (13) (14) , to our knowledge none has used a food frequency questionnaire to provide a comprehensive assessment of nutrient intake.
Very little is known about the relation of ALS to intake of macronutrients (i.e., protein, fat, carbohydrate), and no published studies are known to have evaluated the possible protective effect of dietary antioxidants for this condition in which free radicals may play a role.
Inadequate antioxidant defenses against free radical toxicity have been implicated in the etiology of ALS. Copper/zinc superoxide dismutase (SOD1) is a sulfhydryl enzyme that scavenges toxic superoxide free radicals in the body's tissues, and demonstration of missense mutations in the SOD1 gene in 20 percent of familial ALS cases (2, 15, 16) suggests that impaired defenses against free-radical-induced toxicity play an important role in the pathogenesis of familial ALS. SOD1 gene mutations are less frequent in sporadic ALS cases (2.6 percent) (17) and have not been observed in controls. The sporadic and familial forms of ALS are clinically and pathologically indistinguishable, suggesting that inadequate antioxidant defenses may play a role in both disorders even if specific genetic defects in the SOD1 enzyme are not present. One study that examined markers of oxidative damage in the brains of ALS cases showed evidence of increased oxidative damage in the motor cortex of familial and sporadic ALS cases compared with controls (18) . Given the attention to oxidative stress as a possible etiologic factor in neurodegenerative disease in general, a study in which comprehensive methods were used to assess the role of dietary antioxidants in ALS is timely.
Recent research has indicated that excitatory amino acids of either dietary or endogenous origin may contribute to selective death of particular neuronal populations and thus may play a role in the pathogenesis of ALS and other neurodegenerative disorders. A prominent "excitotoxic theory" of ALS etiology posits that disregulation of glutamate, the brain's primary excitatory neurotransmitter, could result in excessive synaptic levels of glutamate and cause excitotoxic death of motor neurons from repetitive neuronal firing (19, 20) . Diet is a major source of exposure to the excitatory amino acids glutamate and aspartate, yet we know of no published study that has assessed the relation between these nutrients and the risk of ALS.
The primary objective of this study was to assess diet as a predisposing factor for the development of ALS. Of particular interest was intake of macronutrients and antioxidant vitamins. Because of the putative role for excitatory amino acids in the neurodegenerative process of ALS, we also sought to investigate the relation between dietary intake of these amino acids and the risk of ALS.
MATERIALS AND METHODS

Study population
Detailed descriptions of the study population, case definition and ascertainment methods, and control selection methods are provided in prior papers (7, 21) and in the companion paper (22) . To be considered for study eligibility, cases had to be residents of one of three counties of western Washington State (King, Pierce, and Snohomish), aged 18 years or older, and newly diagnosed with ALS by a neurologist during the 4-year study period of 1990-1994 (23) . The case definition required that patients have a progressive motor neuron disease that affected both upper and lower motor neurons (i.e., classic ALS) or have one of the clinical variants of ALS (i.e., progressive muscular atrophy, progressive bulbar palsy). Patients with primary lateral sclerosis were excluded, as were patients whose diagnosis of ALS changed during the year following their initial diagnosis.
Two controls were matched to each case on gender and age within 5 years. Two methods were used to identify controls from the base population. For controls aged 65 years or younger, random digit dialing was used to locate those who were eligible. After this method proved to be inefficient for identifying elderly controls, those older than age 65 years were identified by using Medicare eligibility lists provided by the Health Care Financing Administration.
Over the 4-year study period, 180 newly diagnosed ALS patients met case definition criteria, and 174 (97 percent) agreed to participate in the case-control study. Random digit dialing yieided 87 percent of households that allowed a screening interview, and 87 percent (227/262) of the eligible controls identified in the screening interview agreed to participate in the study. The response rate among eligible controls identified from the Medicare eligibility lists was somewhat lower (68 percent, 121/179). Thus, the overall response rate among eligible controls after combining both sources was 79 percent (348/441). Study information was obtained from a proxy respondent for 20 ALS cases who had died before an interview could take place, and proxy respondents were similarly obtained for each of their matched controls. The food frequency questionnaire was completed by 161 (93 percent) of die cases and 321 (92 percent) of the controls, and all analyses were restricted to these subjects.
Exposure measurement
Data were derived from two sources: an in-person structured interview and a self-administered food frequency questionnaire. Professional interviewers conducted structured in-person interviews to collect information on demographic factors, detailed cigarette smoking history, residential and occupational history, physical trauma and physical activity, height and weight, medical antecedents, and family history of neurodegenerative disorders. Two recent publications give detailed descriptions of the methods used to assess pesticide chemicals (7) and physical activity (21) .
Information about consumption of 98 food items was obtained by using a self-administered semiquantitative food frequency questionnaire (the National Cancer Institute's Health Habits and History Questionnaire) (24) . A validation study had been used to identify 98 food items that together comprised more than 90 percent of the nutrients in the US diet (24) . After the structured interview, the research interviewer gave each subject standardized verbal instructions for completing the food frequency questionnaire and provided a stamped, addressed envelope to return it. Information was elicited regarding the usual frequency of consumption and serving size (small, medium, or large) of each food item. The dietary questionnaire also contained several questions related to the frequency of use of calcium and antioxidant supplements (e.g., multiple vitamins; vitamins A, C, E). Two questions differentiated vitamin-fortified cereals from other cereals, and this information was taken into account when dietary consumption of vitamins and other micronutrients was computed. The food frequency data were edited and coded by a nutritionist, who iden-tified missing and inconsistent responses so that, when necessary, research interviewers could call subjects to request additional information. For each case, dietary habits were assessed for the 1-year period beginning 1 year prior to the onset of symptoms; the same dietary reference date was used for the two matched controls. This approach was chosen to improve the likelihood that dietary habits would be assessed for a time period prior to the onset of clinical symptoms of ALS that could have affected dietary habits.
Data analysis
Statistical analyses were performed by using SAS (25) and EGRET (26) software. Because the study design involved individual matching (two cases for each control matched on age, gender, and respondent type), data were analyzed by using conditional logistic regression, with disease status as the dependent variable (27) . Statistical tests of the regression estimates were based on the chi-squared approximation for the likelihood ratio statistic (28) , and 95 percent confidence intervals were based on Wald's test. Data were provided from proxy respondents for 11 percent of cases and controls; therefore, statistical analyses were conducted according to published recommendations for data sets that include information from both selfand proxy respondents (29, 30) . Analyses were initially conducted separately for the self-respondent and proxy respondent strata, but as no significant differences were observed in effect estimates for these two strata, respondent type was included as a confounder in all analyses.
Estimates of nutrient intake were computed by using the Minnesota Nutrient Data System, a commercially available nutrient software system (31). This software was used with a program provided by investigators at the University of Washington (Seattle) (32) to calculate estimates of daily average intake of the nutrients of interest. The nutrients selected for analysis included macronutrients (protein, carbohydrate, fat), certain types of fat (saturated, monounsaturated, polyunsaturated), certain amino acids (glutamate, aspartate, leucine, phenylalanine, valine, tryptophan), fiber (water soluble, insoluble), alcohol, antioxidants (vitamin A, vitamin C, vitamin E (alpha-tocopherol, gamma-tocopherol)), beta-carotene, selenium, and minerals (calcium, iron, copper, zinc). Statistical analyses for each antioxidant of interest examined the effect of dietary sources alone, the effect of dietary supplement intake alone, and the combined effect of dietary and supplement sources. The Minnesota Nutrient Data System contains amino acid values for 99 percent of the foods in the database; the values were determined on the basis of information from US Department of Agriculture databases, scientific journals, manufacturers' information, textbooks, and other food composition tables. The amino acid values from animal and vegetable protein sources (33) have been incorporated into the Nutrient Data System and were used to estimate the average daily intake of specific amino acids. The food frequency questionnaire contained separate questions regarding consumption of diet and regular soft drinks; therefore, information on the aspartate content of diet soft drinks was incorporated into the nutrient analysis.
For each nutrient or micronutrient of interest, the 25th, 50th, and 75th percentiles of the control group distribution were used to define four quartile-based categories of intake. Odds ratios were calculated for each nutrient by using the lowest quartile of intake as the referent group. Tests of trend for an association between nutrient intake and the risk of ALS were conducted by treating the quartiles of intake as a four-level ordinal variable. All nutrient analyses were adjusted for energy intake by including a continuous term for daily average intake in kilocalories. Other factors associated with disease risk in the overall study or potentially related to dietary habits (e.g., pesticide exposure, body mass index, and level of physical activity) were evaluated as potential confounders. In addition, all logistic regression models used to estimate the effects of nutrient intake included the following covariates: years of formal education and pack-years of cigarette smoking.
RESULTS
The demographic characteristics of the cases and controls are provided in table 1 of the companion paper (22) . The two groups were very similar in terms of age, gender, and race. Compared with controls, ALS cases had fewer years of formal education (mean educational level, 14.0 vs. 13.5 years, respectively); therefore, education was included as a covariate in all analyses. Table 1 compares the cases and controls with respect to body mass index and total caloric intake. ALS cases had a slightly higher mean body mass index than controls 5 years prior to diagnosis (refer to table 1 in the companion paper (22) ). In contrast, the body mass index of cases at diagnosis was lower than that of controls at the matched calendar date, indicating that ALS cases lost body mass presumably as a result of the disease process. ALS cases lost an average of 3.7 pounds (1.68 kg) (standard error = 0.85 pounds (0.39 kg)) between 5 years prior to diagnosis and diagnosis, while controls gained an average of 1.7 pounds (0.77 kg) (standard error = 0.30 pounds (0.14 kg)) during the same time period. Average daily caloric intake at the dietary reference date, 1 year prior to disease onset, was marginally higher in cases than controls; however, a significant trend with increasing levels of caloric intake was not observed. To control for higher caloric intake among cases than controls at the dietary reference date, average daily kilocalorie intake was included as a covariate in all nutrient analyses. We adjusted for total energy intake so the associations of nutrient content with ALS would not reflect casecontrol differences in total caloric intake; as a result, effect estimates for each nutrient are expressed relative to total intake.
The relation between intake of macronutrients and the risk of ALS is given in table 2. Carbohydrate intake was not associated with ALS. The odds ratio for the highest quartile of protein intake was modestly elevated; however, no significant trends were observed for this macronutrient. Significant trends were observed between quartiles of fat intake and the risk of ALS. Fiber intake was inversely associated with ALS; this inverse relation was observed for water-soluble fiber and insoluble fiber. Adjustment for fat intake did not affect the magnitude of the inverse associations with fiber intake (highest vs. lowest quartile, fat-adjusted OR for fiber intake = 0.3, 95% Cl: 0.1, 0.7; p for trend = 0.02).
The associations with particular types of dietary fat are presented in table 3. Because of the inverse association with fiber intake, all effect estimates in table 3 were adjusted for fiber intake in addition to the other covariates. After further adjustment for fiber intake, the positive association with fat intake was only marginally attenuated, and the trend of increasing risk with higher levels of fat intake persisted. The positive association with fat intake was explained largely by the contribution of polyunsaturated fats, saturated fats, and linoleic acid. The association of monounsaturated fats with ALS risk was of a lower magnitude, and a clear doseresponse trend was not observed for this type of fat.
Because of the putative role for glutamate in excitotoxic neuronal injury in ALS, we investigated the relation between dietary intake of glutamate and the risk of ALS (table 4) . To examine the specificity of the associations with glutamate and aspartate, we obtained effect estimates for several other amino acids. Glutamate intake was associated with an increased risk of ALS, with evidence of an increasing trend across quartiles of intake (p -0.02). No significant trends were observed for the associations with intake of aspartate or of other amino acids (table 4) ; however, some of the odds ratios for the highest quartiles of intake were modestly elevated.
Diet soft drinks often contain the excitatory amino acid aspartate (found in the artificial sweetener aspar- • ALS, amyotrophic lateral sclerosis; OR, odds ratio; Cl, confidence interval.
t Conditional logistic regression model included education (years), smoking (pack-years), and energy intake (daily average kcal).
• ALS, amyotrophic lateral sclerosis; OR, odds ratio; Cl, confidence interval.
t Conditional logistic regression model included education (years), smoking (pack-years), energy intake (daily average kcal), and fiber intake (g/day). tame); therefore, we examined the association between consumption of diet soft drinks and ALS. Relative to persons who consumed no diet soft drinks, those who consumed diet soft drinks were not at increased risk of ALS (for <1 diet soft drink/day, adjusted OR = 0.7, 95 percent Cl: 0.4, 1.2; for >1 diet soft drink/day, adjusted OR = 0.7, 95 percent Cl: 0.4, 1.3). Furthermore, ALS cases were not more likely than controls to have consumed Chinese food, artificially sweetened yogurt, or other diet foods that typically contain either monosodium glutamate or aspartate (data not shown). and level of physical activity (data not shown). When the associations between nutrient intake and ALS were evaluated separately within subgroups defined on the basis of gender, age, and respondent type, evidence of effect modification by these variables was lacking (data not shown).
Results for antioxidant vitamins are summarized in table 5. Similar proportions of ALS cases and controls reported having used multivitamins (adjusted OR = 1.2, * ALS, amyotrophic lateral sclerosis; OR, odds ratio; Cl, confidence interval; IU, international units.
t Conditional logistic regression model included education (years), smoking (pack-years), and energy intake (daily average kcal). (table 5) . Similarly, intake of beta-carotene, selenium, and gammatocopherol from food was not associated with ALS (data not shown). Vitamin E intake from food alone was higher among ALS cases than controls; however, when supplement use was also considered, there was no association of total vitamin E intake with the risk of ALS.
Copper and zinc are important factors for the enzymatic activity of SOD1, an enzyme whose mutant form has been associated with the risk of familial ALS (2) . We examined the association of dietary intake of these metals with the risk of ALS, but no associations were observed (for highest vs. lowest quartile of copper intake: adjusted OR = 0.9, p for trend not significant; for highest vs. lowest quartile of zinc intake: adjusted OR = 1.1, p for trend not significant). Similarly, no associations were observed for intake of calcium or iron (data not shown).
DISCUSSION
In this population-based case-control study, higher levels of fat intake and lower levels of fiber intake were associated with an increased risk of ALS; these effects were independent of one another. Persons in the highest quartile of fat intake had a threefold increased risk of ALS compared with those in the lowest quartile. ALS was not associated with intake of monounsaturated fat; however, dose-response associations were observed for all other types of dietary fat (saturated fat, polyunsaturated fat, linoleic acid) and for cholesterol. Persons in the highest quartile of fiber intake had a 70 percent reduced risk of ALS compared with those in the lowest quartile. A positive association was observed with intake of glutamate, an amino acid that has a potential role in inducing excitotoxic neuronal cell death. Despite the hypothesis that ALS could be a free-radical-mediated disease, no significant inverse associations with antioxidant intake from diet or from food supplements were observed.
Previous investigations of dietary factors related to ALS (34) have been limited to a small number of selected food items (11) (12) (13) (14) . Positive associations have been observed with consumption of milk (12) , freshly caught fish (34) , and nuts, rice, and raw meats (11) . Other studies have failed to confirm these associations (13, 14) . Previous investigations of dietary factors were not able to evaluate the associations with macronutnent and micronutrient intake and could not control for the potential confounding effect of total energy intake. Other methodological features of previous studies could have limited the ability to detect dietary associations, including the use of spouses or friends as controls (6, 13, 34), a feature that would be expected to produce overmatching with respect to the dietary factors of interest. Previous studies were also limited in statistical power; the largest study included only 105 cases (11) .
The retrospective assessment of dietary intake in this study was characterized by all of the challenges common to nutritional epidemiology. While there was no a priori reason to suggest that 1 year prior to disease onset was the most relevant exposure window for collecting the dietary data, we had to balance the need to choose a recent period that allowed better dietary recall with the need to avoid a time period during which disease symptoms could have affected dietary habits. As with most studies that use food frequency methods, we assumed that dietary habits during the reference year were representative of usual adult dietary habits.
Compared with cases, controls had a higher level of education and a lower body mass index 5 years before disease diagnosis. This effect could be due to true disease-associated factors or could reflect selective nonparticipation of potential controls with lower educational levels and a higher body mass index. To address this type of selection bias, we adjusted for these factors at the data analysis stage and observed no changes in effect estimates. Nevertheless, years of education was included as a covariate in all analyses. Nondifferential misclassification is inherent when retrospective methods are used to assess diet; however, the usual effect is to decrease the ability to detect associations between diet and disease. Thus, the true associations between nutrients and ALS risk might be larger than could be estimated from this study. Differential misclassification is a possibility, since cases with a given disease may be more motivated to recall serving sizes and frequencies of food consumption. The current study has several strengths that distinguish it from previous studies of dietary factors associated with ALS, including a population-based design, a larger sample size, and restriction to incident ALS cases.
Our findings must be interpreted in light of what is known or hypothesized about the pathogenesis of ALS. After adjustment for the inverse association with fiber intake, we found that intake of dietary fat was positively associated with the risk of ALS. The finding of a significant dose-response relation with fat consumption is intriguing and is consistent with similar associations reported in two recent case-control studies of Parkinson's disease (35, 36) . The positive association with polyunsaturated fat intake is of interest, because the brain is particularly vulnerable to oxidative damage due to relatively high concentrations of polyunsaturated fatty acids (comprised largely of linoleic acid) that are especially prone to lipid peroxidation (5, 37, 38) . Furthermore, the brain consumes one-fourth of the body's total oxygen intake yet has relatively low levels of antioxidant enzymes when compared with other tissues (37) . The membrane levels of polyunsaturated fatty acids are determined largely by dietary intake (38) ; therefore, dietary consumption of higher quantities of polyunsaturated fatty acids could increase the amount of lipid substrate or cause changes in brain lipid composition that could contribute to enhanced lipid peroxidation (37) .
Despite the fact that oxidative stress has been implicated in the etiology of ALS (5, 39), we observed no inverse associations with intake of antioxidants when both dietary and supplement sources of intake were considered. In the transgenic mouse model of ALS, dietary supplementation with vitamin E delayed the onset of clinical disease and slowed disease progression but did not prolong survival (3). In the current study, the average age at diagnosis was compared for users and nonusers of vitamin E supplements; no significant differences were observed. To our knowledge, no published studies have assessed whether administration of vitamin E slows disease progression in ALS patients. Although we failed to observe inverse associations between vitamin E or other antioxidants and the risk of ALS, our assessment of antioxidant intake from supplements was limited to the dietary reference year and did not include information on the lifetime history and duration of supplement use. Collection of this information in future studies would enhance the ability to assess the possible benefits of antioxidant supplementation.
Although a protective effect of dietary fiber had not been hypothesized before we began our study, we found that intake of dietary fiber was inversely associated with ALS, even when the positive association with fat consumption was taken into account. This association was observed for both water-soluble fiber (i.e., from pectins, gums, agars, and mucilages) and insoluble fiber (i.e., from celluloses and lignins). Diet is a potential source of exposure to toxins or excitotoxins that have been implicated in the development of neurodegenerative disorders, and the presence of fiber in the diet could mitigate the effects of such exposure (40) . Two possible mechanisms may explain why dietary fiber may protect against the development of ALS. First, dietary fiber has been shown to cause luminal dilution of potential carcinogens (40, 41) , and this effect could similarly reduce absorption of a dietary toxin associated with ALS. Second, dietary fiber shortens transit time in the large intestine (40) and therefore may reduce the contact time and absorption of a dietary toxin. These explanations are speculative, however, since no specific dietary toxin has yet been definitively associated with ALS. As discussed below, there are several examples of other neurodegenerative disorders caused by ingestion of dietary excitotoxins. The findings with respect to fiber are also interesting in light of the positive associations with glutamate and fat intake. Two studies have demonstrated that supplementation of the rat diet with dietary fiber results in lower levels of glutamate formation from glutamine (42, 43) , and fiber supplementation has also been shown to decrease fat absorption in the bowel (44) .
A primary hypothesis that motivated this study was that dietary intake of glutamate could be related to the risk of ALS because of the putative role of this neurotransmitter in excitotoxic cell death. We found that glutamate intake was positively associated with the risk of ALS, with a more than threefold increase in risk for persons who consumed the highest quantities of glutamate compared with those in the lowest quartile of intake. The usual sources of measurement error (e.g., imprecise quantification of glutamate content in foods, the use of dietary intake from 1 year to reflect usual adult intake) would be expected to introduce nondifferential misclassification and bias the effect estimate for glutamate intake toward unity. A significant association with glutamate intake was observed despite this potential measurement error, and the true association of glutamate intake with the risk of ALS is likely greater than the observed association. Neither can the association be easily explained by recall bias, since ALS cases would be unlikely to be knowledgeable about the particular vegetable and protein sources of glutamate.
The finding of a significant dose-response association of glutamate intake with ALS is interesting when interpreted in view of other neurodegenerative disorders caused by dietary excitotoxins. These disorders include the upper motor neuron disease lathyrism caused by consumption of a glutamate-like excitotoxin in the chickling pea (45) , dystonia associated with ingestion of proprionic acid (46, 47) , limb weakness that occurred after ingestion of seaweed-contaminated mussels that contained the excitotoxin domoic acid (48) , and globus pallidus degeneration in horses caused by ingestion of yellow star thistle that contains very high levels of free glutamate (49) . These natural experiments demonstrate that high dose exposure to acidic amino acids with excitotoxic properties can cause selective loss of particular neuronal populations. Although glutamate is widespread in the food supply, it is possible that exposure to high levels of dietary glutamate, in combination with disordered glutamate metabolism in the brain, could cause excitotoxic cell death of motor neurons.
Glutamate is found in most protein-containing foods such as meats and vegetables, but levels are particu-larly high in tomatoes, mushrooms, milk, and cheese (50) . Glutamate is also produced endogenously. It is released from presynaptic neurons, activates the postsynaptic neuron, and is taken up by glial cells, where it is metabolized to glutamine by the enzyme glutamine synthetase. Glutamine then diffuses back to the neuron and is converted to glutamate (51) . After administration of prolonged or large doses of glutamate, significant increases in brain concentration can occur (52) . Nevertheless, several considerations suggest that evidence related to dietary glutamate be interpreted with caution: 1) much of dietary glutamate is metabolized before it enters systemic circulation (53), 2) the amino acid carrier system for acidic amino acids within the blood brain barrier should maintain glutamate homeostasis (54), and 3) previous studies in rodents suggest that high levels of plasma glutamate must be attained to cause glutamate toxicity in brain (55) .
The hypothesis that high synaptic glutamate levels or disordered glutamate regulation may contribute to ALS pathogenesis is supported by several lines of experimental and clinical evidence: 1) elevated levels of glutamate in serum, cerebrospinal fluid, and brain of ALS patients have been observed in some (56, 57) but not all (58, 59) studies; 2) decreased synaptic transport of glutamate by the high-affinity glutamate transporter has been shown in affected regions of the brain and spinal cord of ALS patients (20) ; and 3) clinical trials have demonstrated that riluzole, an inhibitor of glutamate release, prolongs survival of ALS patients (60) . Together with evidence from our study, these studies suggest that high levels of dietary glutamate, together with disordered glutamate regulation in the brain, could influence the risk of developing ALS.
Before firm conclusions are drawn about the role of dietary factors in ALS, the findings from this study should be replicated with additional studies using comparable methodology. The associations with fat and fiber intake, although striking, had not been hypothesized before we conducted this study. Despite these concerns, the associations are strong and are not readily explainable by predictable sources of study bias. Together with recent evidence that fat intake is positively associated with another neurodegenerative disease (Parkinson's disease) (35, 36) , the finding of associations with fat and fiber intake warrants further study and biologic explanation. Our study suggests that increased intake of antioxidant vitamins is not likely to lower the risk of developing ALS; however, future studies are warranted in which researchers conduct a more detailed assessment of the duration and timing of supplementation for each antioxidant. Consistent with our beginning hypothesis, we observed a significant association between intake of the excitatory amino acid glutamate and the risk of ALS. The findings from this study suggest that modifiable lifestyle factors such as diet and cigarette smoking influence the risk of developing this disease.
